Protein-signaled guided bone regeneration using titanium mesh and Rh-BMP2 in oral surgery: A case report involving left mandibular reconstruction after tumor resection

Open Dentistry Journal

Volumn 6, Issue 1, 2012, Pages 51-55

  Cicciu M ^a   Herford, A S ^b   Stoffella, E ^b   Cervino, G ^c   Cicciu D ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b LOMA LINDA UNIVERSITY   (United States)

^c University of Messina School of Dentistry   (United States)

Author keywords

BMP2 human protein; Bone reconstruction; Bone regeneration; Oral surgery; Titanium mesh

Indexed keywords

EID: 84859508047     PISSN: 18742106     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874210601206010051     Document Type: Article

References (29)

1. Wozney JM. Overview of bone morphogenic proteins. Spine 2002; 27: S2-8.
2. Urist MR. Bone formation by autoinduction. Science 1965; 150: 893-9.
3. Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg 2002; 84: 716-20.
4. Herford AS, Boyne PJ, Williams RP. Clinical applications of rhBMP-2 in maxillofacial surgery. CDA Journal 2007; 35: 335-41.
5. Warnke PH, Springer IN, Wiltfang J, et al. Growth and transplantation of a custom vascularized bone graft in a man. Lancet 2004; 364: 760-70.
6. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest graft harvesting. Clin Orthop 1996; 329: 300-9.
7. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine 1995; 20: 1055-60.
8. Goulet JA, Senunas LE, DeSilva GL. Autogenous iliac crest bone graft. Clin Orthop 1997; 339: 76-81.
9. Burkus JK, Heim SE, Gornet MF, Zdeblick TA. Is infuse bone grafts superior to autograft? an integrated analysis od clinical trials using the LT-CAGE lumbar tapered device. J Spinal Discord Tech 2003; 16: 113-22.
10. Carragee EJ, Mitsunaga KA, Hurwitz EL, Scuderi GJ. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study. Spine J 2011; 11: 511-6.
11. Boden S, Zdelblick T, Sandu H, Heim SE. The use of rhbmp-2 in interbody fusion cages. Spine 2000; 25: 376-81.
12. Burkus J, Gornet M, Dickman C, Zdeblick TA. Anterior lumbar interbody fusion using rhbmp-2 with tapered interbody cages. J Spin Discord Tech 2002; 15: 337-49.
13. Herford AS, Boyne PJ, Rawson, R Williams RP. Bone morphogenetic protein-induced repair of the premaxillary cleft. J Oral Maxillofac Surg 2007; 65: 2136-41.
14. Alonso N, Tanikawa DY, Rida FS, Canan L Jr, Ozawa TO, Rocha DL. Evaluation of maxillary alveolar reconstruction using a resorbable collagen sponge with recombinant human bone morphogenetic protein-2 in cleft lip and palate patients. Tissue Eng Part C Methods 2010; 16: 1185-9.
15. Poyton AR, Lane JM. Safety profile for the clinical use of bone morphogenic proteins in the spine. Spine 2002; 27: S40-8.
16. Itoh K, Udagawa N, Katagiri T, et al. Bone morphogenic protein-2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kB ligand. Endocrinology 2001; 142: 3656-66.
17. Triplett RG, Nevins M, Marx R, et al. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein- 2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 2009; 67: 1947-60.
18. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011; 11: 471-91.
19. Jovanovic SA, Hunt DR, Bernard GW, et al. Long term functional loading of dental implants in rhBMP-2 induced bone. a histological study in the canine ridge augmentation model. Clin Oral Implants Res 2003; 14: 793-803.
20. Degidi M, Scarano A, Piattelli A. Regeneration of the alveolar crest using titanium micromesh with autologous bone and a resorbable membrane. J Oral Implantol 2003; 29: 86-90.
21. Herford AS, Cicciù M. Recombinant human bone morphogenetic protein type 2 jaw reconstruction in patients affected by giant cell tumor. J Craniofac Surg 2010; 21:1970-5.
22. Boyne PJ. Animal studies of application of rhBMP-2 in maxillofacial reconstruction. Bone 1996; 19: 83S-92S.
23. Boyne PJ, Lilly LC, Marx RE, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005; 63:1693-707.
24. Akamaru T, Suh D, Boden S, Kim HS, Minamide A, Louis-Ugbo J. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003; 28: 429-34.
25. Boden SD. The ABCs of BMPs. Orthopaed Nurs 2005; 24: 49-52.
26. Carreon LY, Glassman SD, Brock DC, Dimar JR, Puno RM, Campbell MJ. Adverse events in patients re-exposed to bone morphogenic protein for spine surgery. Spine 2008; 33: 391-3.
27. Poynton AR, Tomin E, Cornwall GB, Zheng F, Lane JM. Resorbable posterolateral graft containment in a rabbit spinal fusion model. Orthopedics 2002; 25: s1173-7.
28. Shah MM, Smyth MD, Woo AS. Adverse facial edema associated with off-label use of recombinant human bone morphogenic protein- 2 in cranial reconstruction for craniosynostosis. J Neurosurg Pediatr 2008; 1: 255-7.
29. Kuklo TR, Groth AT, Anderson RC, Frisch HM, Islinger RB. Recombinant human bone morphogenetic protein-2 for grade III open segmental tibial fractures from combat injuries in Iraq. J Bone Joint Surg Br 2008; 90:1068-72.